Crystal City Dialysis Center in Crystal City, Missouri - Dialysis Center

Crystal City Dialysis Center is a medicare approved dialysis facility center in Crystal City, Missouri and it has 12 dialysis stations. It is located in Jefferson county at 960 S. Truman Blvd., Crystal City, MO, 63019. You can reach out to the office of Crystal City Dialysis Center at (636) 937-5761. This dialysis clinic is managed and/or owned by Davita. Crystal City Dialysis Center has the following ownership type - Profit. It was first certified by medicare in March, 1989. The medicare id for this facility is 262524 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameCrystal City Dialysis Center
Location960 S. Truman Blvd., Crystal City, Missouri
No. of Dialysis Stations 12
Medicare ID262524
Managed ByDavita
Ownership TypeProfit
Late Shifts No

Contact Information


960 S. Truman Blvd., Crystal City, Missouri, 63019
(636) 937-5761

News Archive

Consortium launches ambitious project to transform the treatment of pain

In an effort to address the critical public health need for new, safer and more effective medicines to treat pain, a consortium based at the Laboratory of Systems Pharmacology at Harvard Medical School has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation).

Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.

Brain disconnect leaves teen brain less able to judge trustworthiness

Making a snap decision usually means following your initial reaction - going with your gut. That intuitive feeling sprouts from the limbic system, the evolutionarily older and simpler part of the brain that affects emotion, behavior and motivation.

Pediatric cardiac surgeon receives Gibbon Award from AmSECT

Richard A. Jonas, MD, Chief of Cardiac Surgery and Co-Director of the Children's National Heart Institute at Children's National Medical Center, has received the prestigious Gibbon Award from the American Society of Extra-Corporeal Technology.

High-risk behaviors among injection drug users in Afghanistan

In a report that is among the first to describe the prevalence of HIV and Hepatitis B and C viruses in Afghanistan, a researcher from the University of California, San Diego (UCSD) School of Medicine voiced concerns that increasing injection drug use and accompanying high-risk behavior could lead to an HIV epidemic in Afghanistan.

Read more Medical News

› Verified 6 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Crystal City Dialysis Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1801858857
Organization NameCrystal City Dialysis Center
Doing Business AsRenal Treatment Centers-illinois, Inc
Address960 S Truman Blvd Festus, Missouri, 63028
Phone Number(636) 937-5761

News Archive

Consortium launches ambitious project to transform the treatment of pain

In an effort to address the critical public health need for new, safer and more effective medicines to treat pain, a consortium based at the Laboratory of Systems Pharmacology at Harvard Medical School has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation).

Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.

Brain disconnect leaves teen brain less able to judge trustworthiness

Making a snap decision usually means following your initial reaction - going with your gut. That intuitive feeling sprouts from the limbic system, the evolutionarily older and simpler part of the brain that affects emotion, behavior and motivation.

Pediatric cardiac surgeon receives Gibbon Award from AmSECT

Richard A. Jonas, MD, Chief of Cardiac Surgery and Co-Director of the Children's National Heart Institute at Children's National Medical Center, has received the prestigious Gibbon Award from the American Society of Extra-Corporeal Technology.

High-risk behaviors among injection drug users in Afghanistan

In a report that is among the first to describe the prevalence of HIV and Hepatitis B and C viruses in Afghanistan, a researcher from the University of California, San Diego (UCSD) School of Medicine voiced concerns that increasing injection drug use and accompanying high-risk behavior could lead to an HIV epidemic in Afghanistan.

Read more Medical News

› Verified 6 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data29
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL17

News Archive

Consortium launches ambitious project to transform the treatment of pain

In an effort to address the critical public health need for new, safer and more effective medicines to treat pain, a consortium based at the Laboratory of Systems Pharmacology at Harvard Medical School has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation).

Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.

Brain disconnect leaves teen brain less able to judge trustworthiness

Making a snap decision usually means following your initial reaction - going with your gut. That intuitive feeling sprouts from the limbic system, the evolutionarily older and simpler part of the brain that affects emotion, behavior and motivation.

Pediatric cardiac surgeon receives Gibbon Award from AmSECT

Richard A. Jonas, MD, Chief of Cardiac Surgery and Co-Director of the Children's National Heart Institute at Children's National Medical Center, has received the prestigious Gibbon Award from the American Society of Extra-Corporeal Technology.

High-risk behaviors among injection drug users in Afghanistan

In a report that is among the first to describe the prevalence of HIV and Hepatitis B and C viruses in Afghanistan, a researcher from the University of California, San Diego (UCSD) School of Medicine voiced concerns that increasing injection drug use and accompanying high-risk behavior could lead to an HIV epidemic in Afghanistan.

Read more Medical News

› Verified 6 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center53
    Adult patient months included in Kt/V greater than or equal to 1.2416
    Percentage of adult patients getting regular hemodialysis at the center98
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Consortium launches ambitious project to transform the treatment of pain

    In an effort to address the critical public health need for new, safer and more effective medicines to treat pain, a consortium based at the Laboratory of Systems Pharmacology at Harvard Medical School has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation).

    Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

    Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.

    Brain disconnect leaves teen brain less able to judge trustworthiness

    Making a snap decision usually means following your initial reaction - going with your gut. That intuitive feeling sprouts from the limbic system, the evolutionarily older and simpler part of the brain that affects emotion, behavior and motivation.

    Pediatric cardiac surgeon receives Gibbon Award from AmSECT

    Richard A. Jonas, MD, Chief of Cardiac Surgery and Co-Director of the Children's National Heart Institute at Children's National Medical Center, has received the prestigious Gibbon Award from the American Society of Extra-Corporeal Technology.

    High-risk behaviors among injection drug users in Afghanistan

    In a report that is among the first to describe the prevalence of HIV and Hepatitis B and C viruses in Afghanistan, a researcher from the University of California, San Diego (UCSD) School of Medicine voiced concerns that increasing injection drug use and accompanying high-risk behavior could lead to an HIV epidemic in Afghanistan.

    Read more Medical News

    › Verified 6 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center11
    Adult patient months included in Kt/V greater than or equal to 1.7111
    Percentage of adult patients getting regular peritoneal dialysis at the center86
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    Consortium launches ambitious project to transform the treatment of pain

    In an effort to address the critical public health need for new, safer and more effective medicines to treat pain, a consortium based at the Laboratory of Systems Pharmacology at Harvard Medical School has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation).

    Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

    Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.

    Brain disconnect leaves teen brain less able to judge trustworthiness

    Making a snap decision usually means following your initial reaction - going with your gut. That intuitive feeling sprouts from the limbic system, the evolutionarily older and simpler part of the brain that affects emotion, behavior and motivation.

    Pediatric cardiac surgeon receives Gibbon Award from AmSECT

    Richard A. Jonas, MD, Chief of Cardiac Surgery and Co-Director of the Children's National Heart Institute at Children's National Medical Center, has received the prestigious Gibbon Award from the American Society of Extra-Corporeal Technology.

    High-risk behaviors among injection drug users in Afghanistan

    In a report that is among the first to describe the prevalence of HIV and Hepatitis B and C viruses in Afghanistan, a researcher from the University of California, San Diego (UCSD) School of Medicine voiced concerns that increasing injection drug use and accompanying high-risk behavior could lead to an HIV epidemic in Afghanistan.

    Read more Medical News

    › Verified 6 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Crystal City Dialysis Center with elevated calcium levels.

Patients with hypercalcemia64
Hypercalcemia patient months535
Hypercalcemia patients with serumcalcium greater than 10.2 mg1
Patients with Serumphosphor68
Patients with Serumphosphor less than 3.5 mg/dL5
Patients with Serumphosphor from 3.5 to 4.5 mg/dL28
Patients with Serumphosphor from 4.6 to 5.5 mg/dL34
Patients with Serumphosphor from 5.6 to 7 mg/dL21
Patients with Serumphosphor greater than 7 mg/dL11

News Archive

Consortium launches ambitious project to transform the treatment of pain

In an effort to address the critical public health need for new, safer and more effective medicines to treat pain, a consortium based at the Laboratory of Systems Pharmacology at Harvard Medical School has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation).

Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.

Brain disconnect leaves teen brain less able to judge trustworthiness

Making a snap decision usually means following your initial reaction - going with your gut. That intuitive feeling sprouts from the limbic system, the evolutionarily older and simpler part of the brain that affects emotion, behavior and motivation.

Pediatric cardiac surgeon receives Gibbon Award from AmSECT

Richard A. Jonas, MD, Chief of Cardiac Surgery and Co-Director of the Children's National Heart Institute at Children's National Medical Center, has received the prestigious Gibbon Award from the American Society of Extra-Corporeal Technology.

High-risk behaviors among injection drug users in Afghanistan

In a report that is among the first to describe the prevalence of HIV and Hepatitis B and C viruses in Afghanistan, a researcher from the University of California, San Diego (UCSD) School of Medicine voiced concerns that increasing injection drug use and accompanying high-risk behavior could lead to an HIV epidemic in Afghanistan.

Read more Medical News

› Verified 6 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 45
Patient months included in arterial venous fistula and catheter summaries 336
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment83
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer7

News Archive

Consortium launches ambitious project to transform the treatment of pain

In an effort to address the critical public health need for new, safer and more effective medicines to treat pain, a consortium based at the Laboratory of Systems Pharmacology at Harvard Medical School has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation).

Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.

Brain disconnect leaves teen brain less able to judge trustworthiness

Making a snap decision usually means following your initial reaction - going with your gut. That intuitive feeling sprouts from the limbic system, the evolutionarily older and simpler part of the brain that affects emotion, behavior and motivation.

Pediatric cardiac surgeon receives Gibbon Award from AmSECT

Richard A. Jonas, MD, Chief of Cardiac Surgery and Co-Director of the Children's National Heart Institute at Children's National Medical Center, has received the prestigious Gibbon Award from the American Society of Extra-Corporeal Technology.

High-risk behaviors among injection drug users in Afghanistan

In a report that is among the first to describe the prevalence of HIV and Hepatitis B and C viruses in Afghanistan, a researcher from the University of California, San Diego (UCSD) School of Medicine voiced concerns that increasing injection drug use and accompanying high-risk behavior could lead to an HIV epidemic in Afghanistan.

Read more Medical News

› Verified 6 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary49
Hospitalization Rate in facility293.3 (Worse than Expected)
Hospitalization Rate: Upper Confidence Limit469.1
Hospitalization Rate: Lower Confidence Limit189.5

News Archive

Consortium launches ambitious project to transform the treatment of pain

In an effort to address the critical public health need for new, safer and more effective medicines to treat pain, a consortium based at the Laboratory of Systems Pharmacology at Harvard Medical School has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation).

Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.

Brain disconnect leaves teen brain less able to judge trustworthiness

Making a snap decision usually means following your initial reaction - going with your gut. That intuitive feeling sprouts from the limbic system, the evolutionarily older and simpler part of the brain that affects emotion, behavior and motivation.

Pediatric cardiac surgeon receives Gibbon Award from AmSECT

Richard A. Jonas, MD, Chief of Cardiac Surgery and Co-Director of the Children's National Heart Institute at Children's National Medical Center, has received the prestigious Gibbon Award from the American Society of Extra-Corporeal Technology.

High-risk behaviors among injection drug users in Afghanistan

In a report that is among the first to describe the prevalence of HIV and Hepatitis B and C viruses in Afghanistan, a researcher from the University of California, San Diego (UCSD) School of Medicine voiced concerns that increasing injection drug use and accompanying high-risk behavior could lead to an HIV epidemic in Afghanistan.

Read more Medical News

› Verified 6 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Crystal City Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility24.8 (As Expected)
Readmission Rate: Upper Confidence Limit34.7
Readmission Rate: Lower Confidence Limit16.7

News Archive

Consortium launches ambitious project to transform the treatment of pain

In an effort to address the critical public health need for new, safer and more effective medicines to treat pain, a consortium based at the Laboratory of Systems Pharmacology at Harvard Medical School has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation).

Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.

Brain disconnect leaves teen brain less able to judge trustworthiness

Making a snap decision usually means following your initial reaction - going with your gut. That intuitive feeling sprouts from the limbic system, the evolutionarily older and simpler part of the brain that affects emotion, behavior and motivation.

Pediatric cardiac surgeon receives Gibbon Award from AmSECT

Richard A. Jonas, MD, Chief of Cardiac Surgery and Co-Director of the Children's National Heart Institute at Children's National Medical Center, has received the prestigious Gibbon Award from the American Society of Extra-Corporeal Technology.

High-risk behaviors among injection drug users in Afghanistan

In a report that is among the first to describe the prevalence of HIV and Hepatitis B and C viruses in Afghanistan, a researcher from the University of California, San Diego (UCSD) School of Medicine voiced concerns that increasing injection drug use and accompanying high-risk behavior could lead to an HIV epidemic in Afghanistan.

Read more Medical News

› Verified 6 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Crystal City Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility.82 (As Expected)
SIR: Upper Confidence Limit2.71
SIR: Lower Confidence Limit.14

News Archive

Consortium launches ambitious project to transform the treatment of pain

In an effort to address the critical public health need for new, safer and more effective medicines to treat pain, a consortium based at the Laboratory of Systems Pharmacology at Harvard Medical School has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation).

Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.

Brain disconnect leaves teen brain less able to judge trustworthiness

Making a snap decision usually means following your initial reaction - going with your gut. That intuitive feeling sprouts from the limbic system, the evolutionarily older and simpler part of the brain that affects emotion, behavior and motivation.

Pediatric cardiac surgeon receives Gibbon Award from AmSECT

Richard A. Jonas, MD, Chief of Cardiac Surgery and Co-Director of the Children's National Heart Institute at Children's National Medical Center, has received the prestigious Gibbon Award from the American Society of Extra-Corporeal Technology.

High-risk behaviors among injection drug users in Afghanistan

In a report that is among the first to describe the prevalence of HIV and Hepatitis B and C viruses in Afghanistan, a researcher from the University of California, San Diego (UCSD) School of Medicine voiced concerns that increasing injection drug use and accompanying high-risk behavior could lead to an HIV epidemic in Afghanistan.

Read more Medical News

› Verified 6 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Crystal City Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 40
Transfusion Rate in facility36.8 (As Expected)
Transfusion Rate: Upper Confidence Limit119.4
Transfusion Rate: Lower Confidence Limit13.1

News Archive

Consortium launches ambitious project to transform the treatment of pain

In an effort to address the critical public health need for new, safer and more effective medicines to treat pain, a consortium based at the Laboratory of Systems Pharmacology at Harvard Medical School has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation).

Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.

Brain disconnect leaves teen brain less able to judge trustworthiness

Making a snap decision usually means following your initial reaction - going with your gut. That intuitive feeling sprouts from the limbic system, the evolutionarily older and simpler part of the brain that affects emotion, behavior and motivation.

Pediatric cardiac surgeon receives Gibbon Award from AmSECT

Richard A. Jonas, MD, Chief of Cardiac Surgery and Co-Director of the Children's National Heart Institute at Children's National Medical Center, has received the prestigious Gibbon Award from the American Society of Extra-Corporeal Technology.

High-risk behaviors among injection drug users in Afghanistan

In a report that is among the first to describe the prevalence of HIV and Hepatitis B and C viruses in Afghanistan, a researcher from the University of California, San Diego (UCSD) School of Medicine voiced concerns that increasing injection drug use and accompanying high-risk behavior could lead to an HIV epidemic in Afghanistan.

Read more Medical News

› Verified 6 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Crystal City Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary208
Mortality Rate in facility17.8 (As Expected)
Mortality Rate: Upper Confidence Limit25.1
Mortality Rate: Lower Confidence Limit12.2

News Archive

Consortium launches ambitious project to transform the treatment of pain

In an effort to address the critical public health need for new, safer and more effective medicines to treat pain, a consortium based at the Laboratory of Systems Pharmacology at Harvard Medical School has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation).

Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.

Brain disconnect leaves teen brain less able to judge trustworthiness

Making a snap decision usually means following your initial reaction - going with your gut. That intuitive feeling sprouts from the limbic system, the evolutionarily older and simpler part of the brain that affects emotion, behavior and motivation.

Pediatric cardiac surgeon receives Gibbon Award from AmSECT

Richard A. Jonas, MD, Chief of Cardiac Surgery and Co-Director of the Children's National Heart Institute at Children's National Medical Center, has received the prestigious Gibbon Award from the American Society of Extra-Corporeal Technology.

High-risk behaviors among injection drug users in Afghanistan

In a report that is among the first to describe the prevalence of HIV and Hepatitis B and C viruses in Afghanistan, a researcher from the University of California, San Diego (UCSD) School of Medicine voiced concerns that increasing injection drug use and accompanying high-risk behavior could lead to an HIV epidemic in Afghanistan.

Read more Medical News

› Verified 6 days ago


Dialysis Facility in Crystal City, MO

Crystal City Dialysis Center
Location: 960 S. Truman Blvd., Crystal City, Missouri, 63019
Phone: (636) 937-5761

News Archive

Consortium launches ambitious project to transform the treatment of pain

In an effort to address the critical public health need for new, safer and more effective medicines to treat pain, a consortium based at the Laboratory of Systems Pharmacology at Harvard Medical School has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation).

Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.

Brain disconnect leaves teen brain less able to judge trustworthiness

Making a snap decision usually means following your initial reaction - going with your gut. That intuitive feeling sprouts from the limbic system, the evolutionarily older and simpler part of the brain that affects emotion, behavior and motivation.

Pediatric cardiac surgeon receives Gibbon Award from AmSECT

Richard A. Jonas, MD, Chief of Cardiac Surgery and Co-Director of the Children's National Heart Institute at Children's National Medical Center, has received the prestigious Gibbon Award from the American Society of Extra-Corporeal Technology.

High-risk behaviors among injection drug users in Afghanistan

In a report that is among the first to describe the prevalence of HIV and Hepatitis B and C viruses in Afghanistan, a researcher from the University of California, San Diego (UCSD) School of Medicine voiced concerns that increasing injection drug use and accompanying high-risk behavior could lead to an HIV epidemic in Afghanistan.

Read more Medical News

› Verified 6 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.